| Name | CRANAD-2 |
|---|---|
| Synonyms |
CRANAD 2[SML0842]
Boron, [(1E,6E)-1,7-bis[4-(dimethylamino)phenyl]-1,6-htadiene-3,5-dionato-κO3,κO5]difluoro-, (T-4)- (ACI) (T-4)-[(1E,6E)-1,7-bis[4-(Dimethylamino)phenyl]-1,6-htadiene-3,5-dionato-O3,O5]difluoroboron CRANAD 2 (T-4)-[(1E,6E)-1,7-Bis[4-(dimethylamino)phenyl]-1,6-htadiene-3,5-dionato-kO3,kO5]difluoroboron (T-4)-[(1E,6E)-1,7-bis[4-(dimethylamino)phenyl]-1,6-heptadiene-3,5-dionato-kO3,kO5]difluoro-boron CRANAD-2, Ne-infred Amyloid-beta fluorescent probe 4,6-bis(4-dimethylaminophenyl styryl)- 2,2-difluoro-(1,3,2) dioxaborinin-4-ene-1-ium-2-uide (T -4)-[(1E ,6E )-1,7-Bis[4-(dimethylamino) phenyl]-1,6-htadiene-3,5-dionato-κO ,κO ] difluoroboron inhibit,CRANAD-2,CRANAD 2,CRANAD2,Abeta,Amyloid-β,β-amyloid ptide,Inhibitor |
| Description | CRANAD-2 is a near-infrared (NIR) Aβ plaque-specific fluorescent probe. CRANAD 2 penetrates the blood brain barrier and has a high affinity for Aβ aggregates with a Kd of 38 nM[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C23H25BF2N2O2 |
|---|---|
| Molecular Weight | 410.26500 |
| Exact Mass | 410.19800 |
| PSA | 32.78000 |
| LogP | 4.93870 |
| Storage condition | 2-8°C |
| Water Solubility | DMSO: soluble 0.2 mg/mL, clear (warmed) |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319 |
| Precautionary Statements | P305 + P351 + P338 |
| Hazard Codes | Xi |
| RIDADR | NONH for all modes of transport |